New treatment could offer 18 months protection against severe COVID The monoclonal antibody treatment, AZD7442, recently completed phase 3 clinical trials.
GPs expected to have ‘really important role’ in new COVID therapy Federal Health Minister Greg Hunt has said sotrovimab will be available sometime this week. But uncertainties remain about how patients will access the treatment.
Further setbacks in pursuit of COVID vaccine and ‘cure’ Two randomised controlled trials involving tens of thousands of people have been paused to investigate potential safety concerns.
Resource explains treatment options for patients with severe asthma The Monoclonal antibody therapy for severe asthma information paper has been developed using the latest available evidence.